Annovis Bio, Inc.
ANVS- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001477845
No open-market purchases or sales by Annovis Bio, Inc. insiders were filed in the last 90 days; 61 institutions reported holding it in 13F filings for Q2 2026, worth $20.2M in total; no superinvestor holds it.
13F holders, Q1 2023
Institutional positions in Annovis Bio, Inc. as of Mar 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 23
- 0 vs. Q4 2022
- Shares held
- 752.2K
- +11.3K (+1.5%) vs. Q4 2022
- Total value
- $11.6M
- +$1.66M (+16.7%) vs. Q4 2022
- New holders
- 4
- 7 more added
- Sold out
- 4
- 4 more reduced
Compare with Q4 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ANVS on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 61 | $20.2M |
| Q1 2026 | 56 | $10.5M |
| Q4 2025 | 53 | $14.7M |
| Q3 2025 | 42 | $4.19M |
| Q2 2025 | 42 | $3.93M |
| Q1 2025 | 44 | $3.13M |
| Q4 2024 | 40 | $7.93M |
| Q3 2024 | 35 | $9.50M |
| Q2 2024 | 31 | $5.67M |
| Q1 2024 | 31 | $14.3M |
| Q4 2023 | 36 | $22.5M |
| Q3 2023 | 30 | $10.6M |
| Q2 2023 | 28 | $18.3M |
| Q1 2023 | 23 | $11.6M |
| Q4 2022 | 23 | $9.93M |
| Q3 2022 | 25 | $10.0M |
| Q2 2022 | 26 | $8.73M |
| Q1 2022 | 24 | $11.9M |
| Q4 2021 | 32 | $19.6M |
| Q3 2021 | 38 | $36.2M |
| Q2 2021 | 57 | $109.0M |
| Q1 2021 | 31 | $23.1M |
Institutions, Q1 2023
Shares, value and share of portfolio for each institution holding Annovis Bio, Inc.; share changes are against Q4 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Vanguard Group Inc | 242,571 | $3.74M | 0.00% | 00.0% | Unchanged |
| BlackRock Inc. | 94,246 | $1.45M | 0.00% | −8,950−8.7% | Reduced |
| Geode Capital Management, LLC | 51,650 | $795.9K | 0.00% | +8,092+18.6% | Added |
| Merit Financial Group, LLC | 42,900 | $661.1K | 0.02% | −250−0.6% | Reduced |
| Wescott Financial Advisory Group, LLC | 41,607 | $641.2K | 0.14% | 00.0% | Unchanged |
| Bank of New York Mellon Corp | 34,223 | $527.4K | 0.00% | 00.0% | Unchanged |
| Redmond Asset Management, LLC | 34,010 | $524.1K | 0.18% | 00.0% | Unchanged |
| Sterling Investment Advisors, Ltd. | 33,374 | $514.3K | 0.17% | +900+2.8% | Added |
| Modera Wealth Management, LLC | 30,513 | $470.2K | 0.02% | 00.0% | Unchanged |
| Dimensional Fund Advisors LP | 25,251 | $389.1K | 0.00% | +391+1.6% | Added |
| Bridgeway Capital Management, LLC | 23,600 | $363.7K | 0.01% | 00.0% | Unchanged |
| State Street Corp | 19,235 | $296.4K | 0.00% | +2,100+12.3% | Added |
| Koshinski Asset Management, Inc. | 15,000 | $231.2K | 0.02% | +5,000+50.0% | Added |
| Jane Street Group, LLC | 14,870 | $229.1K | 0.00% | +14,870 | New |
| Susquehanna International Group, LLP | 13,800 | $212.7K | 0.00% | +13,800 | New |
| Cannell Peter B & Co Inc | 10,000 | $154.1K | 0.01% | 00.0% | Unchanged |
| Wealthspire Advisors, LLC | 10,000 | $154.1K | 0.00% | +10,000 | New |
| Wells Fargo & Company | 8,784 | $135.4K | 0.00% | +10.0% | Added |
| Tower Research Capital LLC (TRC) | 2,561 | $39.0K | 0.00% | +1,036+67.9% | Added |
| Advisor Group Holdings, Inc. | 2,156 | $30.5K | 0.00% | −1,210−35.9% | Reduced |
| Morgan Stanley | 1,701 | $26.2K | 0.00% | −27,955−94.3% | Reduced |
| WR Wealth Planners, LLC | 150 | $2.31K | 0.00% | +150 | New |
| Financial Connections Group, Inc. | 25 | $0 | 0.00% | 00.0% | Unchanged |
| IFP Advisors, Inc | 0 | $0 | 0.00% | −4,600−100.0% | Sold out |
| Bank of America Corp | 0 | $0 | 0.00% | −1,074−100.0% | Sold out |
| Rockefeller Capital Management L.P. | 0 | $0 | 0.00% | −1,000−100.0% | Sold out |
| Citigroup Inc | 0 | $0 | 0.00% | −6−100.0% | Sold out |